SCHEMBL18966596

SCHEMBL18966596

CCCCCCOC(=O)c1cccc2c1OB(O)[C@@H](NC(=O)CCCC)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ TSHR P16473 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ TP53 P04637 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ TRPA1 O75762 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CNR1 P21554 3/20 0.38
▸ CNR2 P34972 3/20 0.38
▸ MMP2 P08253 1/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ HDAC1 Q13547 3/20 0.35
▸ HDAC2 Q92769 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18966850 0.99 TSHR (0.44) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18966817 0.96 ALDH1A1 (0.46) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18966815 0.95 TSHR (0.44) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18957134 0.93 ALDH1A1 (0.46) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18966812 0.93 ALDH1A1 (0.46) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18957026 0.93 ALDH1A1 (0.46) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL17337124 0.92 TSHR (0.43) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL17337127 0.92 TSHR (0.43) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18957092 0.92 TSHR (0.45) ALDH1A1TSHRLMNATP53CYP3A4
SCHEMBL18957087 0.92 TSHR (0.45) ALDH1A1TSHRLMNATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017100537-A1 BETA-LACTAMASE INHIBITORS VenatoRx Pharmaceuticals, Inc. (US) 2017-06-15 — — WO disclosed
Send feedback